Management of Implantable Cardioverter Defibrillator Recipients: Care Beyond Guidelines

François Philippon1, Laurence D Sterns2, Pablo B Nery3

  • 1Quebec Heart and Lung Institute, Laval University, Québec, Québec, Canada.

Insights

This guide addresses common clinical scenarios for implantable defibrillators (ICDs) not covered in prior guidelines. It offers practical advice on device programming, replacement, and managing complex patient situations for better care.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Device Technology

Background:

  • Existing guidelines for implantable cardioverter-defibrillators (ICDs) do not cover all common clinical scenarios.
  • Optimal management of ICD patients requires addressing device programming, replacement, and complex clinical situations.

Purpose of the Study:

  • To provide recommendations for common clinical scenarios involving ICDs not detailed in previous guidelines.
  • To offer guidance on device programming, shock reduction, and pacing optimization.
  • To discuss important considerations during device replacement and management of specific patient conditions.

Main Methods:

  • Review and synthesis of current clinical knowledge and expert opinion.
  • Discussion of practical aspects of ICD management, including programming and replacement.
  • Consideration of complex patient scenarios requiring a multidisciplinary approach.

Main Results:

  • Recommendations for programming implantable defibrillators to enhance detection and minimize shocks (appropriate and inappropriate).
  • Guidance on minimizing ventricular pacing to improve patient outcomes.
  • Discussion of technical aspects of device replacement, including vascular access and extraction.
  • Consideration of managing components subject to advisories.
  • Strategies for managing patients with terminal illnesses, recurrent ventricular tachycardia, electrical storms, and system infections.

Conclusions:

  • Effective management of patients with implantable defibrillators necessitates a comprehensive, team-based approach.
  • Addressing common but previously unaddressed clinical scenarios improves patient care and outcomes.
  • Updated guidance is crucial for optimizing the use of implantable defibrillator technology.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
442
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
649
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
405
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
291
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
438